| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypertension, Vol 24, 699-705, Copyright © 1994 by American Heart Association
P Ernsberger, RJ Koletsky, JS Baskin and M Foley
Very-low-calorie diets lower blood pressure acutely in obese humans and
rats. However, refeeding after dietary restriction produces mild
hypertension in rats. Refeeding hypertension was characterized in
genetically obese spontaneously hypertensive rats (obese SHR, Koletsky
rat), a model of genetic obesity and hypertension. Obese SHR were fed a
restricted diet (Optifast) for 12 days, refed ad libitum for 28 days,
dieted again for 12 days, and then refed 4 days and killed. Control obese
SHR and lean SHR littermates were fed ad libitum continuously. Dietary
restriction led to rapid weight loss followed by prompt regain to baseline
weight after return to unrestricted food intake. Heart rate fell with
institution of the low-calorie diet and returned to baseline on refeeding.
Blood pressure became elevated during refeeding in dieted obese SHR
relative to ad libitum fed obese SHR controls. The fall in blood pressure
after ganglionic blockade with chlorisondamine was exaggerated in refed
obese SHR, and cardiac beta-adrenergic receptors were downregulated. Both
of these findings imply increased sympathetic tone. The left ventricular
wall was thicker in the refed obese SHR than in the ad libitum fed obese
SHR. Shorter cycles of weight loss and regain in lean SHR led to transient
increases in blood pressure and heart rate. Cycles of dietary restriction
and refeeding in obese SHR elicit sustained blood pressure elevation via
sympathetic activation and exacerbate cardiac hypertrophy. Drastic
fluctuations in nutrient intake may not be advantageous in hypertension.
ARTICLES
Refeeding hypertension in obese spontaneously hypertensive rats
Department of Medicine, Case Western Reserve School of Medicine, Cleveland, Ohio 44106.
This article has been cited by other articles:
![]() |
A. Bitto, D. Altavilla, A. Bonaiuto, F. Polito, L. Minutoli, V. Di Stefano, D. Giuliani, S. Guarini, V. Arcoraci, and F. Squadrito Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome J. Endocrinol., March 1, 2009; 200(3): 367 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Velliquette, J. E. Friedman, J. Shao, B. B. Zhang, and P. Ernsberger Therapeutic Actions of an Insulin Receptor Activator and a Novel Peroxisome Proliferator-Activated Receptor {gamma} Agonist in the Spontaneously Hypertensive Obese Rat Model of Metabolic Syndrome X J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 422 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Minhas, S. A. Khan, S. V. Y. Raju, A. C. Phan, D. R. Gonzalez, M. W. Skaf, K. Lee, A. D. Tejani, A. P. Saliaris, L. A. Barouch, et al. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy J. Physiol., June 1, 2005; 565(2): 463 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. S. Harris, D. B. Hausman, and T. J. Bartness Compensation for partial lipectomy in mice with genetic alterations of leptin and its receptor subtypes Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2002; 283(5): R1094 - R1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Swoap Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2473 - H2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |